A wearable
artificial kidney may be a viable dialysis technology that can give people with
end-stage kidney disease the freedom to move around during treatment, according
to the results of a new clinical trial. The technology may become an
alternative to conventional hemodialysis for people with end-stage kidney
disease. Present-day treatment generally requires three sessions a week on a
stationary machine that restricts patients’ ability to walk around while it is
attached and running.
In contrast,
a wearable device would allow patients to be mobile and untethered. It could
also provide additional benefits from longer sessions or more frequent days of
dialysis. The clinical trial of a prototype for such a device was performed
with seven patients at University of Washington Medical Centre in the US. The patients
were treated with the device for up to 24 hours. The US Food and Drug
Administration authorized trial was conducted to determine the safety and
efficacy of the device. The device effectively cleared the blood of waste
products, like urea, creatinine and phosphorous, while also removing excess
water and salt.
No comments:
Post a Comment